Drug Development
Elan Reports First Quarter 2007 Financial Results
Published in Medical Patent Week, May 13th, 2007
Elan Corporation, plc today announced its first quarter 2007 financial results and provided a business update. Commenting on Elan's business, Kelly Martin, Elan's president and chief executive officer, said, "2007 started strongly in terms of revenue growth, operating improvements and continued advancements in the pipeline. Of particular note this quarter is the receiving of Fast Track designation from the FDA for ELND-005 in the area of Alzheimer's, continued progress in the drug technology portfolio and associated royalty streams, as well as the progress made in the Tysabri patient uptake for MS in both Europe and the US. Our focus and commitment continue to center on delivering results...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Week
Source: Medical Patent Week (2007-05-13)
More Articles from Medical Patent Week
- Angioplasty
Abiomed Completes Enrollment of Pilot Clinical Trial for Impella 2.5 Circulatory Support System - Biotechnology
Prana Expands Senior Management Team with Appointment of Two US-based Pharmaceutical Executives - Bipolar Disorders
Brain Networks Strengthened by Closing Ion Channels - Cell Biology
IR BioSciences Appoints Celgene Executive Dr. Robert Hariri to Its Board of Directors - Cell Therapy
ThermoGenesis Announces Record Revenues and Key Executive Changes - Drug Resistance
Faltering Antibiotics Market to Recover and Surpass $25 Billion by 2010 - More from this issue of Medical Patent Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
